Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

STAB

Statera BioPharma (STAB)

Statera BioPharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:STAB
FechaHoraFuenteTítuloSímboloCompañía
15/03/202307:00GlobeNewswire Inc.Statera Biopharma Signs Letter of Intent for Merger with Worksite LabsNASDAQ:STABStatera BioPharma Inc
03/03/202309:47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:STABStatera BioPharma Inc
27/02/202305:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:STABStatera BioPharma Inc
15/02/202308:10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:STABStatera BioPharma Inc
01/02/202315:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STABStatera BioPharma Inc
01/02/202315:10Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:STABStatera BioPharma Inc
14/11/202216:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STABStatera BioPharma Inc
06/10/202205:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STABStatera BioPharma Inc
23/09/202205:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:STABStatera BioPharma Inc
26/08/202206:49GlobeNewswire Inc.Nasdaq Resumes Trading in Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
25/08/202210:48GlobeNewswire Inc.Nasdaq Halts Statera Biopharma, Inc.NASDAQ:STABStatera BioPharma Inc
14/06/202206:30GlobeNewswire Inc.Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting FirmNASDAQ:STABStatera BioPharma Inc
23/05/202215:05GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q FilingNASDAQ:STABStatera BioPharma Inc
13/05/202206:30GlobeNewswire Inc.Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY ProductsNASDAQ:STABStatera BioPharma Inc
27/04/202215:10GlobeNewswire Inc.Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose NaltrexoneNASDAQ:STABStatera BioPharma Inc
22/04/202216:26GlobeNewswire Inc.Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K FilingNASDAQ:STABStatera BioPharma Inc
13/04/202215:05GlobeNewswire Inc.Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to EntolimodNASDAQ:STABStatera BioPharma Inc
13/04/202206:00PR Newswire (US)Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera BiopharmaNASDAQ:STABStatera BioPharma Inc
31/03/202215:05GlobeNewswire Inc.Statera Biopharma, Inc. Files Form 12b-25NASDAQ:STABStatera BioPharma Inc
28/03/202206:30GlobeNewswire Inc.Statera Biopharma, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022NASDAQ:STABStatera BioPharma Inc
24/03/202216:28GlobeNewswire Inc.Statera Biopharma Announces Closing of $5.7 Million Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202208:29GlobeNewswire Inc.Statera Biopharma Announces Pricing of $5.7 Million Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202206:38GlobeNewswire Inc.CORRECTION -- Statera Biopharma Announces Proposed Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
22/03/202206:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:STABStatera BioPharma Inc
21/03/202218:27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:STABStatera BioPharma Inc
21/03/202215:50GlobeNewswire Inc.Statera Biopharma Announces Proposed Underwritten Public OfferingNASDAQ:STABStatera BioPharma Inc
08/03/202215:15GlobeNewswire Inc.Statera Biopharma Announces Revised Preliminary Revenue and Financial Results of Fiscal Year 2021NASDAQ:STABStatera BioPharma Inc
07/03/202206:30GlobeNewswire Inc.Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 PlatformNASDAQ:STABStatera BioPharma Inc
02/03/202208:08GlobeNewswire Inc.CORRECTION - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19NASDAQ:STABStatera BioPharma Inc
02/03/202206:30GlobeNewswire Inc.Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19NASDAQ:STABStatera BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:STAB